See Trial IntelX in Action at Booth #32165
WCG is attending the 2026 ASCO Annual Meeting, where leaders come together to inspire and advance the oncology field.
With decades of experience supporting oncology programs, WCG helps streamline study start‑up, regulatory review, and site operations — so research teams can focus on what matters most: moving critical studies forward.
Our teams understand the scientific complexity, regulatory rigor, and operational pressure that accompany hematology and oncology trials—and partner closely to reduce friction and accelerate activation.
WCG will be onsite in Chicago showcasing ClinSphere® Trial IntelX, our unified trial intelligence solution designed to bring foresight to trial planning.
Built on insights from 80,000+ complete digitized protocols and 40,000+ operationally benchmarked trials, Trial IntelX enables teams to:
- Surface enrollment and timeline risk before protocol lock.
- Quantify participant and site burden during study design.
- Compare country and site options using real performance data.
- Pressure‑test design assumptions with scenario modeling.
- Reduce costly amendments by addressing risk upfront.
Meet with WCG at ASCO
Meet with the WCG team at Booth #32165 to see how Trial IntelX supports smarter trial planning and helps teams anticipate challenges, align decisions earlier, and move forward with confidence.